iSpecimen Inc. Files 8-K: Material Agreements Entered and Terminated
Ticker: ISPC · Form: 8-K · Filed: 2024-07-03T00:00:00.000Z
Sentiment: neutral
Topics: material-agreement, agreement-termination
TL;DR
iSpecimen Inc. signed and terminated key deals on June 28th. Big changes ahead?
AI Summary
On June 28, 2024, iSpecimen Inc. entered into a Material Definitive Agreement and also terminated a Material Definitive Agreement. The company, incorporated in Delaware with its principal executive offices in Lexington, MA, filed this 8-K report on July 3, 2024, detailing these significant events.
Why It Matters
This filing indicates significant changes in iSpecimen Inc.'s contractual relationships, which could impact its operations, partnerships, and financial standing.
Risk Assessment
Risk Level: medium — The termination of a material definitive agreement suggests potential disruption or a shift in business strategy that could carry financial or operational risks.
Key Players & Entities
- iSpecimen Inc. (company) — Registrant
- June 28, 2024 (date) — Date of earliest event reported
- July 3, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Lexington, MA (location) — Principal executive offices
FAQ
What was the nature of the Material Definitive Agreement entered into by iSpecimen Inc. on June 28, 2024?
The filing indicates the entry into a Material Definitive Agreement on June 28, 2024, but the specific details of this agreement are not provided in the provided text.
What was the reason for the termination of the Material Definitive Agreement by iSpecimen Inc. on June 28, 2024?
The filing states that iSpecimen Inc. terminated a Material Definitive Agreement on June 28, 2024, but the specific reasons for this termination are not detailed in the provided text.
When did iSpecimen Inc. file this Form 8-K with the SEC?
iSpecimen Inc. filed this Form 8-K on July 3, 2024.
In which state is iSpecimen Inc. incorporated?
iSpecimen Inc. is incorporated in Delaware.
What is the address of iSpecimen Inc.'s principal executive offices?
The principal executive offices of iSpecimen Inc. are located at 450 Bedford Street, Suite 1010, Lexington, MA 02420.
From the Filing
0001104659-24-077817.txt : 20240703 0001104659-24-077817.hdr.sgml : 20240703 20240703170022 ACCESSION NUMBER: 0001104659-24-077817 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240628 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240703 DATE AS OF CHANGE: 20240703 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 241100798 BUSINESS ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 8-K 1 tm2418868d1_8k.htm FORM 8-K false 0001558569 0001558569 2024-06-28 2024-06-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): June 28, 2024   iSpecimen Inc. (Exact name of registrant as specified in its charter)   Delaware   001-40501   27-0480143 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   450 Bedford Street Lexington , MA 02420 (Address of principal executive offices, including zip code)   Registrant’s telephone number, including area code: ( 781 ) 301-6700   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company x   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨             Item 1.01 Entry into a Material Definitive Agreement.   On July 2, 2024, iSpecimen Inc., a Delaware corporation (the “Company”), entered into a commercial lease (the “Woburn Lease”) with Cummings Properties, LLC (the “Landlord”) for an office space of approximately 2,273 square feet at 8 Cabot Road, Suite 1800, Woburn, MA 01801 (the &#